262 related articles for article (PubMed ID: 20040913)
1. Directed evolution of a novel adeno-associated virus (AAV) vector that crosses the seizure-compromised blood-brain barrier (BBB).
Gray SJ; Blake BL; Criswell HE; Nicolson SC; Samulski RJ; McCown TJ; Li W
Mol Ther; 2010 Mar; 18(3):570-8. PubMed ID: 20040913
[TBL] [Abstract][Full Text] [Related]
2. Crossing the blood-brain barrier with AAV vectors.
Liu D; Zhu M; Zhang Y; Diao Y
Metab Brain Dis; 2021 Jan; 36(1):45-52. PubMed ID: 33201426
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus vector-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity.
McCown TJ
Neurotherapeutics; 2009 Apr; 6(2):307-11. PubMed ID: 19332324
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated virus-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity in vivo.
McCown TJ
Mol Ther; 2006 Jul; 14(1):63-8. PubMed ID: 16730475
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo.
Foti S; Haberman RP; Samulski RJ; McCown TJ
Gene Ther; 2007 Nov; 14(21):1534-6. PubMed ID: 17713567
[TBL] [Abstract][Full Text] [Related]
6. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
[TBL] [Abstract][Full Text] [Related]
7. The influence of epileptic neuropathology and prior peripheral immunity on CNS transduction by rAAV2 and rAAV5.
Weinberg MS; Blake BL; Samulski RJ; McCown TJ
Gene Ther; 2011 Oct; 18(10):961-8. PubMed ID: 21490684
[TBL] [Abstract][Full Text] [Related]
8. Capsid Engineering Overcomes Barriers Toward Adeno-Associated Virus Vector-Mediated Transduction of Endothelial Cells.
Zhang L; Rossi A; Lange L; Meumann N; Koitzsch U; Christie K; Nesbit MA; Moore CBT; Hacker UT; Morgan M; Hoffmann D; Zengel J; Carette JE; Schambach A; Salvetti A; Odenthal M; Büning H
Hum Gene Ther; 2019 Oct; 30(10):1284-1296. PubMed ID: 31407607
[TBL] [Abstract][Full Text] [Related]
9. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
Hammond SL; Leek AN; Richman EH; Tjalkens RB
PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic liabilities of in vivo viral vector tropism: adeno-associated virus vectors, NMDAR1 antisense, and focal seizure sensitivity.
Haberman R; Criswell H; Snowdy S; Ming Z; Breese G; Samulski R; McCown T
Mol Ther; 2002 Oct; 6(4):495-500. PubMed ID: 12377191
[TBL] [Abstract][Full Text] [Related]
11. Safe and stable noninvasive focal gene delivery to the mammalian brain following focused ultrasound.
Stavarache MA; Petersen N; Jurgens EM; Milstein ER; Rosenfeld ZB; Ballon DJ; Kaplitt MG
J Neurosurg; 2018 Apr; 130(3):989-998. PubMed ID: 29701544
[TBL] [Abstract][Full Text] [Related]
12. Directed evolution of adeno-associated virus (AAV) as vector for muscle gene therapy.
Yang L; Li J; Xiao X
Methods Mol Biol; 2011; 709():127-39. PubMed ID: 21194025
[TBL] [Abstract][Full Text] [Related]
13. Comparative Analysis of the Capsid Structures of AAVrh.10, AAVrh.39, and AAV8.
Mietzsch M; Barnes C; Hull JA; Chipman P; Xie J; Bhattacharya N; Sousa D; McKenna R; Gao G; Agbandje-McKenna M
J Virol; 2020 Feb; 94(6):. PubMed ID: 31826994
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma.
Thorsen F; Afione S; Huszthy PC; Tysnes BB; Svendsen A; Bjerkvig R; Kotin RM; Lønning PE; Hoover F
J Gene Med; 2006 Sep; 8(9):1131-40. PubMed ID: 16810631
[TBL] [Abstract][Full Text] [Related]
15. Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain.
Markakis EA; Vives KP; Bober J; Leichtle S; Leranth C; Beecham J; Elsworth JD; Roth RH; Samulski RJ; Redmond DE
Mol Ther; 2010 Mar; 18(3):588-93. PubMed ID: 20010918
[TBL] [Abstract][Full Text] [Related]
16. Application of polyploid adeno-associated virus vectors for transduction enhancement and neutralizing antibody evasion.
Chai Z; Sun J; Rigsbee KM; Wang M; Samulski RJ; Li C
J Control Release; 2017 Sep; 262():348-356. PubMed ID: 28789965
[TBL] [Abstract][Full Text] [Related]
17. Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates.
Dodiya HB; Bjorklund T; Stansell J; Mandel RJ; Kirik D; Kordower JH
Mol Ther; 2010 Mar; 18(3):579-87. PubMed ID: 19773746
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Sialic Acid Dependence Influences the Central Nervous System Transduction Profile of Adeno-associated Viruses.
Albright BH; Simon KE; Pillai M; Devlin GW; Asokan A
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894463
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of gene delivery to the brain using AAV and ultrasound depends on serotypes and brain areas.
Kofoed RH; Dibia CL; Noseworthy K; Xhima K; Vacaresse N; Hynynen K; Aubert I
J Control Release; 2022 Nov; 351():667-680. PubMed ID: 36179767
[TBL] [Abstract][Full Text] [Related]
20. Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development.
Lin EJ; Richichi C; Young D; Baer K; Vezzani A; During MJ
Eur J Neurosci; 2003 Oct; 18(7):2087-92. PubMed ID: 14622242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
